艾丽品牌怎么样 申请店铺

重庆华森制药股份有限公司位于重庆市荣昌区工业园区和重庆两江新区，占地170余亩，注册资金3.6亿元，总资产6.8亿元。年产值15亿元，实现利税过1.2亿元，年上缴税金8300余万元。2014由国家工信部发布全国制药工业排名,重庆华森制药全国化学药排名第96位。

华森制药已发展成为一家集药品研发、生产、销售于一体的国家重点高科技术企业。华森制药是全国守合同重信用企业，重庆市重点医药企业，重庆市创新型试点企业，重庆市政府打造千亿级医药产业重点龙头企业，A级纳税人企业，银行系统AAA级信用企业，三峡库区移民安置企业，“华森”被评为全国重点保护品牌。被国家科技部列为“国家中药现代化科技产业基地”，“中药先进工艺技术中心”，“国家生物产业基地龙头企业”。由国家工信部与医药工业研究总院联合评为“2015年中国创新力医药企业”。

华森制药以人为本，尊重人才，现有员工1000余人，其中博士、硕士、正副教授、研究员、高级工程师等高级专业技术人员占11%，中级专业技术人员占38%，大专以上文化程度人员达95%以上，为公司长远发展奠定了坚实的人才基础。华森制药还组建了“院士专家工作站”，标志着华森的人才战略站上了一个新的台阶。先后承担“国家十二五重大新药创制项目”，“国家863高科技计划项目”“国家火炬计划项目”多项。

华森制药本着“以科技为先导”的指导思想，重视新药研发机构建设和企业核心技术创新工作，建成了有强劲创新力的科技成果转化平台。近年来，应用现代制药先进技术：CO2超临界萃取技术、超声振荡提取技术、大孔吸附树脂技术、低温超微粉碎技术已达国际先进水平等。

先后研制成功的有国家级新药，大分子层状网络结构的新型胃药——威地美(铝碳酸镁片)，攻防兼备，安全保胃，抗酸抗胆汁保护胃黏膜，三效合一整体解决胃壁疾病，是治疗胆汁反流性胃炎的首选，并被列为《国家基本医疗保险药品》;先后荣获高新技术产品、重点新产品、重庆市名牌产品、消费者信得过产品、重庆市科技进步奖三等奖。威地美原料通过美国FDA认证。

都梁软胶囊属国家中药保护品种、独家专利药品、专治头痛,预防复发,标本兼治,多环节控制头痛发作,是原发性头痛的新选择，临床用于治疗偏头痛等病症取得满意疗效。该品应用现代中药先进技术生产,工艺成熟,质量稳定,疗效理想,安全性高,生产环保、节能,经国家科技部门组织专家认定,列入国家火炬计划项目,并获得《国家火炬计划项目证书》，被列为《国家基本医疗保险药品》。重庆市科技进步奖三等奖。

甘桔冰梅片为独家纯中药制剂，开音更利咽，方便又持久，是治疗早期声带小结首选药物，并列为《国家基本医疗保险药品》。

新药痛泻宁颗粒为全球唯一治疗IBS(肠易激综合征)的天然植物药，于2009年1月取得国家生产批文和新药证书，并获得国际发明专利。痛泻宁颗粒多环节多靶点治疗IBS，预防复发。

欧得曼盐酸特拉唑嗪胶囊，为长效高选择性α1受体阻滞剂，WHO推荐治疗前列腺肥大和高血压的一线用药，并被列为《国家基本医疗保险药品》。

水王螺旋藻胶囊为国家中药保护品种，为临床升高血细胞和增强免疫力的首选药，被列为《国家基本医疗保险药品》。

八味芪龙颗粒、胆舒软胶囊、脑脉欣、六味安神胶囊、长松(聚乙二醇4000)、傲承(苦参素冻干粉针)、甘草酸二铵冻干粉针、阿魏酸钠粉针、曲克芦丁注射液、等产品，以疗效肯定、副作用小、质量可靠、价格适中、完美的服务赢得消费者信赖。

目前华森制药形成了以消化系统治疗药为支柱，心脑血管疾病用药和肿瘤中药治疗药物为辅助的产品构架。华森制药拥有片剂、散剂、颗粒剂、硬胶囊剂、软胶囊剂、粉针剂、冻干粉针剂、小容量注射剂、原料合成和植物药提取等11条西部一流的药品GMP生产线。拥有国家发明专利36项，上市产品达80余个，具有高品质、高附加值的特点。华森制药正在研发的国家级新药品种有十余个，包括具有抗癌抑癌的纯天然植物药及国家I类、Ⅱ类新药，并相继与美国、加拿大等国外研发中心，以保持企业可持久的科技创新及发展能力。

为建成坚实的药品产业化平台，华森制药始终坚持“以人为本，市场营销为中心”的企业发展理念，汇集了一大批高、中级专业技术人才，铸造了一支综合素质高、专业技能强的销售队伍。重视学术推广平台建设，建成了遍及全国的专家网络，在全国设有400余个办事处，市场网络已遍布全国28个省，并逐步向海外延伸。

华森制药以“责任心生命力”为企业理念，秉承“诚信、勤奋、感恩、学习、团队、创新”的企业精神领导团队，以“兴民族工业，树中国品牌”为己任，正带领全体华森人以坚实的步伐，为促健康发展、创建国内一流、做百年老店的制药企业而奋斗。

Chongqing Huasen Pharmaceutical Co., Ltd. is located in Chongqing Rongchang District Industrial Park and Chongqing Liangjiang New Area, covering an area of more than 170 mu, with a registered capital of 360 million yuan and a total asset of 680 million yuan. The annual output value is 1.5 billion yuan, the profit and tax is over 120 million yuan, and the annual tax payment is over 83 million yuan. In 2014, the Ministry of industry and information technology of the people's Republic of China released the national pharmaceutical industry ranking, and Chongqing Huasen pharmaceutical ranked 96th in the national chemical medicine ranking. Huasen pharmaceutical has developed into a national key high-tech enterprise integrating drug R & D, production and sales. Huasen pharmaceutical is a national contract abiding and trustworthy enterprise, a key pharmaceutical enterprise in Chongqing, an innovative pilot enterprise in Chongqing, a leading pharmaceutical industry enterprise of 100 billion level built by Chongqing municipal government, a taxpayer enterprise of a level, a credit enterprise of AAA level in the banking system, and a resettlement enterprise in the Three Gorges Reservoir area. Huasen is rated as a national key protection brand. It is listed by the Ministry of science and technology of the people's Republic of China as the "national modern science and technology industrial base of traditional Chinese medicine", "advanced technology center of traditional Chinese medicine", "leading enterprise of national biological industry base". The Ministry of industry and information technology of the people's Republic of China and the General Institute of pharmaceutical industry jointly rated as "2015 China's innovative pharmaceutical enterprise". Huasen pharmaceutical has over 1000 employees, including 11% of senior professional and technical personnel such as doctors, masters, professors and associate professors, researchers, senior engineers, 38% of middle-level professional and technical personnel, and more than 95% of personnel with college or above education level, which has laid a solid talent foundation for the development of the director general. Huasen pharmaceutical has also set up "academician and expert workstation", which marks a new step of Huasen's talent strategy. It has successively undertaken "national 12th Five Year Plan major new drug development project", "National 863 high tech plan project" and "national torch plan project". In line with the guiding ideology of "science and technology as the guide", Huasen pharmaceutical attaches great importance to the construction of new drug R & D institutions and the core technology innovation of enterprises, and has built a strong and innovative platform for the transformation of scientific and technological achievements. In recent years, the application of modern pharmaceutical advanced technology: CO2 supercritical extraction technology, ultrasonic vibration extraction technology, macroporous adsorption resin technology, low-temperature ultra-fine grinding technology has reached the international advanced level. Weidemai (magnesium aluminate tablet), a new gastric medicine with the structure of macromolecular layered network, has been developed successively. It has the advantages of both attack and defense, safety and stomach protection, anti acid and anti bile protection for gastric mucosa, three effects in one to solve the gastric wall disease. It is the first choice for the treatment of bile reflux gastritis and listed as the national basic medical insurance drug; It has won the third prize of high-tech products, key new products, Chongqing famous brand products, consumer trusted products and Chongqing Science and technology progress award. Weidemai raw materials have passed the FDA certification. Duliang soft capsule is a kind of national traditional Chinese medicine protection product, exclusive patent medicine, specialized in treating headache, preventing recurrence, treating both symptoms and symptoms, and controlling headache attack in multiple links. It is a new choice of primary headache, and has a satisfactory clinical effect in treating migraine and other diseases. The product is produced with advanced technology of modern Chinese medicine, with mature technology, stable quality, ideal curative effect, high safety, environmental protection and energy saving. It has been recognized by experts organized by the national science and Technology Department, listed in the national torch plan project, obtained the national torch plan project certificate, and listed as the national basic medical insurance drug. Third prize of Chongqing Science and technology progress award. Ganju Bingmei tablet is an exclusive pure Chinese medicine preparation, which is more convenient and durable. It is the first choice for the treatment of early vocal nodule and listed as the national basic medical insurance drug. Tongxieling granules, the only natural plant medicine for IBS (irritable bowel syndrome), obtained the national production approval and new drug certificate in January 2009, and obtained the international invention patent. Tongxieling granule is used to treat IBS and prevent recurrence. Odyman terazosin hydrochloride capsule is a long-acting and highly selective α 1 receptor blocker. Who recommends the first-line drug for the treatment of prostate hypertrophy and hypertension, and it is listed as the national basic medical insurance drug. Shuiwang Spirulina capsule is a kind of national traditional Chinese medicine protection product. It is the first choice drug to increase blood cells and enhance immunity. It is listed as the national basic medical insurance drug. Baweiqilong granule, Danshu soft capsule, Naomaixin, Liuwei Anshen capsule, Changshong (polyethylene glycol 4000), Aocheng (Oxymatrine freeze-dried powder injection), diammonium glycyrrhizinate freeze-dried powder injection, sodium ferulate powder injection, Troxerutin Injection, and other products have won the trust of consumers with definite curative effect, small side effects, reliable quality, moderate price and perfect service. At present, Huasen pharmaceutical has formed a product framework with digestive system medicine as the pillar, cardiovascular and cerebrovascular disease medicine and tumor Chinese medicine as the auxiliary. Huasen pharmaceutical has 11 first-class GMP production lines in Western China, including tablet, powder, granule, hard capsule, soft capsule, powder injection, freeze-dried powder injection, small volume injection, raw material synthesis and plant medicine extraction. With 36 national invention patents and more than 80 listed products, it has the characteristics of high quality and high added value. Huasen pharmaceutical is developing more than ten national new drug varieties, including pure natural plant drugs with anti-cancer and anti-cancer, national class I and class II new drugs, and has successively cooperated with foreign R & D centers in the United States, Canada and other countries to maintain the sustainable scientific and technological innovation and development ability of the enterprise. In order to build a solid pharmaceutical industrialization platform, Huasen pharmaceutical always adheres to the enterprise development concept of "people-oriented, marketing as the center", gathers a large number of high and intermediate professional and technical personnel, and creates a sales team with high comprehensive quality and strong professional skills. We attach great importance to the construction of academic promotion platform, and have established a nationwide expert network, with more than 400 offices nationwide, and a market network covering 28 provinces nationwide, and gradually extending overseas. Huasen pharmaceutical takes "sense of responsibility and vitality" as the corporate philosophy, adheres to the corporate spirit of "integrity, diligence, gratitude, learning, team, innovation" as the leading team, takes "rejuvenating national industry, building Chinese brand" as its own responsibility, and is leading all Huasen people to make solid steps to strive for promoting healthy development, creating a first-class domestic pharmaceutical enterprise that has been a century old shop.

本文链接： https://brand.waitui.com/508c8f949.html 联系电话：023-67622999